Ignite Creation Date:
2024-05-06 @ 3:14 PM
Last Modification Date:
2024-10-26 @ 1:45 PM
Study NCT ID:
NCT04564040
Status:
COMPLETED
Last Update Posted:
2020-12-29
First Post:
2020-08-27
Brief Title:
A Study in Healthy Subjects to Assess Bioavailability Proportion of a Drug Which Enters the Circulation to Have an Active Effect of Acalabrutinib Tablet and Protonpump Inhibitor Effect Members of a Class of Medications That Inhibits in Gastric Acid Production for Rabeprazole
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Organization Data
Organization:
AstraZeneca
Class:
INDUSTRY
Study ID:
D8223C00005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AstraZeneca
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Parexel | INDUSTRY |